Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Dekker

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Scientific Reports|April 3, 2026
Biodiversity of natural versus planted mangrove forests across latitudes in Guangdong China with seven new records and potential new speciesSadar Aslam, Malik Wajid Hussain Chan, Trond Roger Oskars, et al.
Molecular Biotechnology|December 19, 2006
Epidermal growth factor receptor-induced activator protein 1 activity controls density-dependent growth inhibition in normal rat kidney fibroblastsJorrit J Hornberg, Henk Dekker, Peter H J Peters, et al.
Cardiovascular Research|February 5, 2003
Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjectsBastiaan van Dam, Victor W M van Hinsbergh, Coen D A Stehouwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancerRutger Middelburg, Richard R de Haas, Henk Dekker, et al.
Experimental & Molecular Medicine|December 17, 2016
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancerMariette Labots, Kristy J Gotink, Henk Dekker, et al.
Biochemical Pharmacology|May 13, 2019
Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell lineNele Van Der Steen, Alessandro Leonetti, Kaylee Keller, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancerElena Galvani, Elisa Giovannetti, Francesca Saccani, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 11, 2015
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanibKristy J Gotink, Maria Rovithi, Richard R de Haas, et al.
European Journal of Medicinal Chemistry|February 3, 2020
Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cellsStella Cascioferro, Giovanna Li Petri, Barbara Parrino, et al.
International Journal of Molecular Sciences|December 17, 2024
Evaluation of Spliceosome Protein SmD2 as a Potential Target for Cancer TherapyJing Li, Peiyu Li, Tereza Brachtlova, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Scientific Reports|April 3, 2026
Biodiversity of natural versus planted mangrove forests across latitudes in Guangdong China with seven new records and potential new speciesSadar Aslam, Malik Wajid Hussain Chan, Trond Roger Oskars, et al.
Molecular Biotechnology|December 19, 2006
Epidermal growth factor receptor-induced activator protein 1 activity controls density-dependent growth inhibition in normal rat kidney fibroblastsJorrit J Hornberg, Henk Dekker, Peter H J Peters, et al.
Cardiovascular Research|February 5, 2003
Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjectsBastiaan van Dam, Victor W M van Hinsbergh, Coen D A Stehouwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancerRutger Middelburg, Richard R de Haas, Henk Dekker, et al.
Experimental & Molecular Medicine|December 17, 2016
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancerMariette Labots, Kristy J Gotink, Henk Dekker, et al.
Biochemical Pharmacology|May 13, 2019
Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell lineNele Van Der Steen, Alessandro Leonetti, Kaylee Keller, et al.
Neoplasia (New York, N.Y.)|January 30, 2013
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancerElena Galvani, Elisa Giovannetti, Francesca Saccani, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 11, 2015
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanibKristy J Gotink, Maria Rovithi, Richard R de Haas, et al.
European Journal of Medicinal Chemistry|February 3, 2020
Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cellsStella Cascioferro, Giovanna Li Petri, Barbara Parrino, et al.
International Journal of Molecular Sciences|December 17, 2024
Evaluation of Spliceosome Protein SmD2 as a Potential Target for Cancer TherapyJing Li, Peiyu Li, Tereza Brachtlova, et al.
Pageof 4